GDF15-フェロプトーシスの調節:胃がん発症におけるp62/Keap1/Nrf2経路の解明
Lixia Yang1,2, Hong Li3, Yun Yang4
1Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical, Changsha Medical University, Changsha, Hunan, China.
Molecular carcinogenesis
|August 21, 2025
まとめ
GDF15はp62/Keap1/Nrf2経路を阻害し,フェロプトーシスを促進し,胃がんの進行を抑制する. この発見は 胃がん治療の新たな戦略を提示しています
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- 胃がん (GC) は,高い死亡率を持つ世界的な健康問題です.
- GCの進行を促す分子メカニズムを理解することは 効果的な治療法の開発に不可欠です
- フェロプトーシスという 細胞死亡の制御された形態は 癌治療の潜在的標的として 登場しています
研究 の 目的:
- 成長分化因子15 (GDF15) がp62/Keap1/Nrf2経路を通じてフェロプトーシスを調節する役割を調査する.
- 細胞の成長,移動,侵入を含む胃がんの進行に対するGDF15の影響を明らかにする.
- 胃がんの治療対象としてGDF15を研究する.
主な方法:
- GDF15の発現は,胃粘膜とがん細胞系におけるウェスタン・ブロットを用いて分析された.
- 細胞機能 (活力,成長,移動,侵入) は,CCK-8によるコロニー形成,傷の治癒,およびトランスウェル解析を用いて評価された.
- フェロプトーシスマーカー (ROS,MDA,GSH,GPX4,Fe2+),ミトコンドリア膜ポテンシャル,およびp62/Keap1/Nrf2経路はインビトロおよびインビボマウスモデルで評価されました.
主要な成果:
- GDF15の高い発現はGC細胞で観察され,GDF15の静止は腫瘍の成長と転移を抑制した.
- GDF15の静止は,ROSとMDAを増加させ,p62/Keap1/Nrf2経路を抑制することによってフェロプトーシスを促進しました.
- Nrf2活性化剤NK-252は,GDF15の静止作用を逆転させ,フェロプトーシスを減らし,p62/Keap1/Nrf2経路を再活性化しました.
結論:
- GDF15の静止はフェロプトーシスを促進し,p62/Keap1/Nrf2経路を阻害することで胃がんの進行を抑制します.
- GDF15はフェロプトーシスを調節し,胃がん細胞の行動に影響を与える上で重要な役割を果たします.
- GDF15とp62/Keap1/Nrf2経路を標的にすることは,胃がんに対する有望な治療戦略です.
関連する概念動画
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K


